Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Adherium Ltd. ( (AU:ADR) ).
Adherium Limited reported a significant 55% increase in device shipments for the quarter ending September 2025, driven by the launch of a new patient education call center and strong partnerships. The company also highlighted groundbreaking results from the iCARE study, demonstrating high adherence rates and validating the Hailie® platform’s value for healthcare systems. These developments are expected to strengthen Adherium’s market position and drive future growth.
More about Adherium Ltd.
Adherium Limited is a leading digital health company specializing in integrated digital health solutions and connected respiratory medical devices. The company focuses on enhancing patient adherence and engagement through its Hailie® platform, which is widely used in respiratory care for conditions such as COPD and asthma.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.39M
For detailed information about ADR stock, go to TipRanks’ Stock Analysis page.